(11) 98705-3426
TrademarkIQ iconTrademarkIQ
Back to search
Official data from USPTO

REMPLIR

Did you know this trademark is already registered in United States?

Before investing in name, identity, and promotion, validate collision risk and registration strategy to avoid wasting time and budget.

Active USPTO registrationType: WordOffice: United States

Quick snapshot

REMPLIR

ST13

US500000079310798

Class

5, 10

Filing

79310798

Registration

6776828

Risk and opportunity diagnosis

Executive reading for naming, filing, and monitoring decisions.

USPTO status

Active USPTO registration

Case type

Application and registration

Recorded events

29

Latest update

11/07/2022

Trademark type

Word

Nice classes

5, 10

Filing date

04/13/2021

Registration date

07/05/2022

Expiration date

-

Complete case details

Structured fields from the responsible authority and the official record.

Status date

07/05/2022

Last transaction

07/05/2022

Responsible office

United States Patent and Trademark Office

Status code

700

Official register

Principal Register

Drawing code

4

Owner type

11

Owner location

AU

Examiner

BELL, MARLENE D

Law office

M90

Current location

PUBLICATION AND ISSUE SECTION

Holders and representatives

Holders

Orthocell Limited

Representatives

Matthew J. Stark Price Heneveld LLP

Technical classification

Nice Classes

Class 5Class 10

Vienna Codes

No Vienna codes available.

Goods and services

Class 5

Stem cells for medical purposes; collagen for medical use; biodegradable implants being implantable scaffolds comprising biological materialsliving cells for use in guided tissue regeneration; surgical implant materials being implantable scaffolds comprising biological materialsliving cells for use in guided tissue regeneration; implantable materials being implantable scaffolds comprising biological materialsliving cells for use in guided tissue regeneration; implants being implantable scaffolds comprising biological materialsliving cells for use in guided tissue regeneration; surgical implants comprised of living tissues; therapeutic agents for tissue regeneration; therapeutic biological productsbiological cell cultures for medical purposes; medical preparationsmedical preparations for tissue regeneration; guided tissue regeneration materialsmaterials for the regeneration of bone and soft tissueliving tissue and nerve tissue; biological preparations for medical purposes for use in guided tissue regeneration for tissue repair; tissue-regenerative medical preparations for use in regeneration of damaged bone and soft tissueliving tissue and nerve tissue; tissues for medical use being living cells and implantable scaffolds comprising biological materials; surgical dressings incorporating collagen; surgical dressings made from collagen; tissue-regenerative pharmaceutical preparations for use in regeneration of damaged bone and soft tissueliving tissue and nerve tissue; tissues for surgical usefor use in regeneration of damaged bone and soft tissueliving tissue and nerve tissue

Class 10

Artificial orthopaedic implants; biodegradable bone fixation implants made of artificial materials and non-living biological materials; dental implants made of artificial materials and non-living biological materials; medical implantsimplants made from artificial biomaterialssynthetic collagenfor use in the regeneration of bone and soft tissuenerve tissue; orthopaedic implantsimplants made from artificial biomaterials for use in the regeneration of bone and soft tissuenerve tissue; surgical implants prosthesis made of artificial materials and non-living biological materials for use in human medicine; surgical implants comprised of artificial materials and non-living biological materials; surgical implants comprised of artificial materials and non-living biological materials for replacing human tissue; surgical implants comprised of artificial materials and non-living biological materials for use in guided tissue regeneration; surgical prosthesesimplantable scaffolds comprising artificial materials and non-living biological materials for the regeneration of bone and soft tissuenerve tissue; artificial skin for surgical purposes; orthopaedic materialsorthopaedic materials made from artificial biomaterials for use in the regeneration of bone and soft tissuenerve tissue; artificial materials and non-living biological materials for use in guided tissue regenerationimplantable scaffolds comprising artificial biomaterials for the regeneration of bone and soft tissuenerve tissue; artificial replacement materials for human tissuesynthetic collagen based scaffolding materials; replacement materials for animal tissuesynthetic collagen based scaffolding materials

Publications

History of USPTO decisions and trademark events.

29 publications found

FINO

FINAL DECISION TRANSACTION PROCESSED BY IB

11/07/2022

FICS

FINAL DISPOSITION NOTICE SENT TO IB

10/13/2022

FIMP

FINAL DISPOSITION PROCESSED

10/13/2022

FICR

FINAL DISPOSITION NOTICE CREATED, TO BE SENT TO IB

10/05/2022

NRCC

NOTICE OF REGISTRATION CONFIRMATION EMAILED

07/05/2022

R.PR

REGISTERED-PRINCIPAL REGISTER

07/05/2022

GPNX

NOTIFICATION PROCESSED BY IB

05/03/2022

NPUB

OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED

04/19/2022

PUBO

PUBLISHED FOR OPPOSITION

04/19/2022

OPNS

NOTIFICATION OF POSSIBLE OPPOSITION SENT TO IB

04/13/2022

OP2R

NOTICE OF START OF OPPOSITION PERIOD CREATED, TO BE SENT TO IB

04/13/2022

NONP

NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED

03/30/2022

CNSA

APPROVED FOR PUB - PRINCIPAL REGISTER

03/12/2022

XAEC

EXAMINER'S AMENDMENT ENTERED

03/11/2022

GNEN

NOTIFICATION OF EXAMINERS AMENDMENT E-MAILED

03/11/2022

GNEA

EXAMINERS AMENDMENT E-MAILED

03/11/2022

CNEA

EXAMINERS AMENDMENT -WRITTEN

03/11/2022

TEME

TEAS/EMAIL CORRESPONDENCE ENTERED

02/01/2022

CRFA

CORRESPONDENCE RECEIVED IN LAW OFFICE

02/01/2022

TROA

TEAS RESPONSE TO OFFICE ACTION RECEIVED

02/01/2022

RFNT

REFUSAL PROCESSED BY IB

11/05/2021

RFCS

NON-FINAL ACTION MAILED - REFUSAL SENT TO IB

10/12/2021

RFRR

REFUSAL PROCESSED BY MPU

10/12/2021

RFCR

NON-FINAL ACTION (IB REFUSAL) PREPARED FOR REVIEW

09/26/2021

CNRT

NON-FINAL ACTION WRITTEN

09/25/2021

DOCK

ASSIGNED TO EXAMINER

09/19/2021

MAFR

APPLICATION FILING RECEIPT MAILED

05/22/2021

NWOS

NEW APPLICATION OFFICE SUPPLIED DATA ENTERED

05/18/2021

REPR

SN ASSIGNED FOR SECT 66A APPL FROM IB

05/13/2021

Continuous trademark protection

Get notified about every new filing that threatens REMPLIR or your mark.

Professional 24-month watch service: we monitor USPTO for you and alert you in time to oppose — before conflicts become losses.